Oct 14, 2021 — 3 min read
We asked our Lunit ambassadors from around the world to share a message to all women in general and of their expectation of Lunit AI in regards to early diagnosis of Breast Cancer.
. . .
“Do not delay getting mammography and annual check-ups after the age of 40. If your breast tissue is dense (consult your doctor), do not forget to add the breast ultrasound examination to the mammography screening. If you have breast cancer or ovarian cancer history in your family, have your risks calculated for breast cancer. If you have a high risk of breast cancer, it is important to be screened with breast MRI or Contrast-Enhanced Mammography every two years.
Please do not neglect your breast health, inform your relatives as well.”
. . .
“Well-informed women are empowered women, always seek credible information to guide your decisions regarding your health. Technology has grown in leaps and bounds so the options from diagnosis to management has likewise evolved. Don’t let your misapprehensions and fears keep you in the dark.”
. . .
“Breast cancer does not discriminate. Age is no barrier. As October is Breast Cancer Awareness Month, I would like to emphasize the importance of preventive medicine and self-care.
Knowledge is power but only if women take charge and are proactive in regards to their breast health by showing up yearly or every 2 years for their breast screening from the age of 40 or younger if they have a significant family history.
I would like to empower all women to make well-informed decisions regarding their breast health.
To all the mums, aunties, grandparents, besties and women in your community, I am encouraging you to make time to see your GPs for your routine clinical breast examination, discuss and learn about your personal risk profile, book your mammogram appointment and discuss the need for a supplementary breast ultrasound check.
To the men in this community, I encourage you to lovingly prompt those special women in your life for them to make time and prioritise their breast health check and imaging tests.”
. . .
“Women are courageous, strong and compassionate creatures that have the potentials to achieve great things. I believe that the cornerstone of the civilized, strong societies is the healthy woman. She should be a priority for herself and be aware of her well being inside out.
Breast cancer is the most common type of women’s cancer in both developed and less-developed countries. Women should seek professional advice and guidance not only at the times of her breast is not feeling well but also at regular annual screens to assure herself, early detect and conquer that distressing disease.”
. . .
“Doing a regular MMG screening has shown to save lives and reduce breast cancer mortality by nearly 30%. Medical fraternity personnel are constantly trying their best to improve breast cancer detection by advances in mammographic techniques and also by providing excellent AI based second reader softwares like Lunit INSIGHT MMG.
Now it’s your turn to take an active step to defeat this disease. Do regular mammogram for yourself and your loved ones. This can save life and save breasts! Every woman deserves right of early detection and better prognosis! and You too!”
Using AI to better manage COVID-19
Cognitive biases and augmented intelligence in radiology
Uncertainty and Deep Learning
What do medical studies say about AI for COVID-19 management?
What do the medical journals say about AI-powered mammography?
Research Using Lunit Demo Website
Lunit Presents AI-powered Pathologic Classification of Immune Phenotype that Predicts Response to Immunotherapy at USCAP 2021
What do the medical journals say about AI-powered chest x-ray interpretation?
Join our webinar with Dr. Fredrik Strand
From retrospective to prospective trials of AI in breast cancer screening
AACR 2021 - Lunit Presents Abstracts Demonstrating the Potential of its AI Biomarker in Cancer Treatment
Will AI Identify Breast Cancer Better Than Radiologists in Actual Clinical Screening?
Case of the Month | Where Is Breast Cancer?
AI-based Analysis of Cancer Tissue Predicts Response to Immunotherapy--Findings to Be Presented at ASCO 2021
Clinical Application of Lunit AI For Chest Radiography and Mammography to Be Presented at AOCR 2021
Lunit Secures $26M Investment from Guardant Health in a Strategic Funding Round
A Multi-reader Study Finds Unnecessary CT Exams Can Be Reduced by 30% When Analyzing Chest Radiographs with AI
Fujifilm Introduces its AI-powered Product for Chest X-ray in Japan, in Collaboration with Lunit
Lunit Collaborates with Intel to Provide AI Solutions to CPU-Based Customers in Need of Effective X-ray Diagnosis
Lunit AI Applied to Clinical Trial for Drug Development for the First Time--Findings Presented at ESMO 2021
Case of the Month (Chest x-ray)
COVID Global User Testimonials
Where is Cancer?
TimeSformer: Is Space-Time Attention All You Need for Video Understanding?
Evaluation curves for object detection algorithms in medical images
Lunit to Participate in RSNA 2021, Presenting its New AI Solutions for Digital Breast Tomosynthesis and Chest CT
Lunit Presents Studies at SITC 2021, Highlighting the Effectiveness of AI in Predicting Response to Immunotherapy in a Clinical Trial Setting
Lunit Gets FDA Nod for AI-based Chest X-ray Triage Solution, Developed for Sorting of Emergency Cases
Lunit's AI Software for Breast Cancer Detection, Lunit INSIGHT MMG, Wins FDA Clearance
Research Backs Clinical Efficacy of Lunit's Radiology AI Products; Abstracts to be Presented at RSNA 2021
Medical AI Provider Lunit Raises $61M in Funding Round Led By Major Global Healthcare Investors
Lunit Named to the 2021 CB Insights Digital Health 150 -- List of Most Innovative Digital Health Startups
Lunit Obtains MDSAP Certificate, Granted Fast-Track Regulatory Process in Major Countries
Lunit to Showcase Chest and Breast Radiology AI in Arab Health 2022
Baheya Foundation, Egypt’s Premier Destination for Breast Cancer, Adopts Lunit AI to Enhance Early Screening
Lunit AI Demonstrates Accuracy in Practical Assessment of Cancer Tissue-Findings to Be Presented at USCAP 2022
Case of the Month (Chest x-ray) - Tuberculosis Case
Medical AI Startup Lunit gets Preliminary Approval to go Public on KOSDAQ
Lunit AI solution for PD-L1 expression analysis receives CE mark
Lunit AI Biomarker PD-L1 Demonstrates Clinical Efficacy as Diagnostic Aid in Cancer Treatment–Published in the European Journal of Cancer